University Research Lecturer
José Leal joined the Health Economics Research Centre in January 2004, having completed his MSc in Health Economics at the University of York in 2003. Since joining HERC, José has worked on several projects, including an economic evaluation of genetic testing for sudden cardiac death, an economic evaluation of MS/MS screening for Medium Chain Acyl-CoenzymeA Dehydrogenase Deficiency, elicitation of expert opinion and several cost-of-illness studies.
José has recently completed a doctoral thesis at the University of Oxford on the use of multi-parameter evidence synthesis to inform economic evaluations. His current research interests include the use of expert opinion to inform decision models, evidence synthesis frameworks in economic evaluation and individual patient level modelling.
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Kent S. et al, (2019), PharmacoEconomics
The clinical and cost effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised trial
BEARD D. et al, (2019), The Lancet
Impact of achieving primary care targets in Type 2 diabetes on health outcomes and healthcare costs
Keng MJ. et al, (2019), Diabetes, Obesity and Metabolism
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.
Leal J. et al, (2019), Pharmacoeconomics, 37
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy.
Leal J. et al, (2019), Eye (Lond), 33, 640 - 647